On October 16, 2025, MIRA Pharmaceuticals, Inc. sold 1,751,000 shares at $2.19 each, raising approximately $3.84 million for the company, reflecting a 66% premium over the previous day's closing price. This was done through an at-the-market equity offering to multiple institutional investors without any warrants.